Satoshi Kayukawa

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial

Kazuyuki Shimada, Motoko Yamaguchi, Yoshiko Atsuta et al. · The Lancet Oncology · 2020 · 97 citations

Medicine, Oncology, Pharmacotherapy +15

Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells

Takaomi Sanda, Takashi Okamoto, Yuto Uchida et al. · Leukemia · 2007 · 43 citations

Life Sciences, Cell Biology, Molecular Biology +17

Overexpression of carboxylesterase‐2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT‐11), for multiple myeloma

Hiroki Yano, Satoshi Kayukawa, Shinsuke Iida et al. · Cancer Science · 2008 · 38 citations · Full text

Medicine, Oncology, Pharmacology +13

Chemo-Immunotherapy Using Lentinan for the Treatment of Gastric Cancer with Liver Metastases

Kenji Ina, Ryuichi Furuta, Takae Kataoka et al. · Medical Sciences · 2016 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17

Symptoms and health-related quality of life in patients with newly diagnosed multiple myeloma: a multicenter prospective cohort study

Nana Suzuki, Toru Okuyama, Tatsuo Akechi et al. · Japanese Journal of Clinical Oncology · 2021 · 13 citations

Medicine, Internal Medicine, Oncology +17